119 related articles for article (PubMed ID: 7517992)
1. PSA screening.
Hahn DL; Roberts R
J Fam Pract; 1994 Jul; 39(1):12. PubMed ID: 7517992
[No Abstract] [Full Text] [Related]
2. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases].
Kato M; Okada K
Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140
[TBL] [Abstract][Full Text] [Related]
3. Should men over the age of 65 years receive PSA screening? Argument against.
Albertsen PC
Nat Clin Pract Urol; 2008 May; 5(5):232-3. PubMed ID: 18349860
[No Abstract] [Full Text] [Related]
4. Screening for prostate cancer utilizing the prostate-specific antigen (PSA).
Halperin EC
N C Med J; 1993 Sep; 54(9):443-6. PubMed ID: 7694161
[No Abstract] [Full Text] [Related]
5. Is screening for prostate cancer the current gold standard?--"no".
Kramer BS; Gohagan JK; Prorok PC
Eur J Cancer; 1997 Mar; 33(3):348-53. PubMed ID: 9155515
[No Abstract] [Full Text] [Related]
6. How valuable is prostate-specific antigen screening?
Handler S
Minn Med; 1996 Jun; 79(6):2. PubMed ID: 8692130
[No Abstract] [Full Text] [Related]
7. Cruciferous vegetables and prostate cancer risk: confounding by PSA screening.
Kristal AR; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1265. PubMed ID: 15247142
[No Abstract] [Full Text] [Related]
8. [Early detection of cancer of the prostate. Pros and cons].
Hoesl CE; Altwein JE
MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
[TBL] [Abstract][Full Text] [Related]
9. [Prostatic specific antigen in practice in 1997].
Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC
Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634
[TBL] [Abstract][Full Text] [Related]
10. Clinical inquiries. Is prostate-specific antigen (PSA) screening indicated for any subgroup of men?
Fisher M; Beck E
J Fam Pract; 2002 Feb; 51(2):113. PubMed ID: 11978206
[No Abstract] [Full Text] [Related]
11. Screening for prostate cancer.
Brawley OW; Ankerst DP; Thompson IM
CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
[TBL] [Abstract][Full Text] [Related]
13. New trial data do not end the PSA screening debate.
Vastag B
J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364
[No Abstract] [Full Text] [Related]
14. An evaluation of prostate-specific antigen as a screening test for prostate cancer.
Dorr VJ; Williamson SK; Stephens RL
Arch Intern Med; 1993 Nov; 153(22):2529-37. PubMed ID: 7694555
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen testing to screen for prostate cancer.
Budenholzer BR
J Fam Pract; 1995 Sep; 41(3):270-8. PubMed ID: 7544400
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer screening is experimental.
Cox B
N Z Med J; 1996 Mar; 109(1017):63-4. PubMed ID: 8606819
[No Abstract] [Full Text] [Related]
17. Should men over the age of 65 years receive PSA screening? Argument in favor.
Whitson JM; Konety BR
Nat Clin Pract Urol; 2008 May; 5(5):230-1. PubMed ID: 18349861
[No Abstract] [Full Text] [Related]
18. What to do with an abnormal PSA test.
Loeb S; Catalona WJ
Oncologist; 2008 Mar; 13(3):299-305. PubMed ID: 18378540
[TBL] [Abstract][Full Text] [Related]
19. How to use PSA to screen for prostate cancer.
Little B; Young M
Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer: screening and treatment options.
Horger DC; Clarke HS
J S C Med Assoc; 2003 Apr; 99(4):85-7. PubMed ID: 12762154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
